Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-29

Clinical Trial Update: Comparative Bioavailability Study of Azithromycin 200mg/5mL Suspension Following a 600mg Dose Under Fed Conditions [Phase 1]

View source ↗

Summary

This Clinical Trials update reports completion of a Phase 1 comparative bioavailability study of azithromycin 200 mg/5 mL suspension after a 600 mg dose under f…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)

Snippet

Sponsor: Sandoz | Conditions: Infections | Phase 1 | Status: COMPLETED